Korean Pharma Finds Own Way To Collaborative And Open Innovation

Taking into consideration global and domestic trends, South Korean pharmas are increasingly finding their own strategies to seek open innovation and collaborations to develop novel new drugs. Two leading firms from the country shared their know-how and showcased successful open innovation cases during a recent gathering organized by a national industry association.

Innovation concept presented by a consultant in management on webinar screen
Yuhan, Daewoong's Open Innovation Strategies

More from South Korea

More from Focus On Asia